Insulet (PODD) Acquisitions (2022 - 2023)
Insulet's (PODD) quarterly Acquisitions came in at $3.0 million in Q1 2023, down 88.46% YoY from $26.0 million in Q1 2022, and down 88.46% on a QoQ basis from $26.0 million in Q1 2022.
Insulet (PODD) Acquisitions (2022 - 2023) Analysis & Trends
Insulet (PODD) has 2 years of Acquisitions data on file, last reported at $3.0 million in Q1 2023.
- Quarterly Acquisitions fell 88.46% year-over-year to $3.0 million in Q1 2023, while the trailing twelve-month figure through Dec 2023 was $3.0 million (down 88.46% YoY) and the FY2023 annual result came in at $3.0 million, down 88.46% from the prior year.
- Acquisitions declined to $3.0 million in Q1 2023, from $26.0 million in the prior quarter.
- In the past five years, Acquisitions ranged from a high of $26.0 million in Q1 2022 to a low of $3.0 million in Q1 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.61 Bn | 194.01 Bn | 7.27 Bn | - |
| 2 | Stryker | 127.81 Bn | 124.34 Bn | 4.50 Bn | 437.00 Mn |
| 3 | Medtronic | 119.04 Bn | 109.82 Bn | 6.41 Bn | 406.00 Mn |
| 4 | Boston Scientific | 73.68 Bn | 73.14 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.96 Bn | 47.71 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.36 Bn | 32.41 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.83 Bn | 31.72 Bn | 2.18 Bn | -4.00 Mn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | -3.49 Mn |
| 9 | Steris | 23.06 Bn | 22.58 Bn | 684.20 Mn | 16.00 Mn |
| 10 | Insulet | 10.34 Bn | 9.81 Bn | 562.60 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 3.00 Mn |
| Mar 31, 2022 | 26.00 Mn |